Wednesday, February 1, 2012 - Thursday, February 2, 2012
7:00 a.m. - 5:00 p.m.
Add to Calendar
Monday, January 30, 2012 12:00 p.m.
Where The Lodge at Torrey Pines
11480 North Torrey Pines Road
La Jolla, California 92037
The Premier Partnering Event of 2012
BIOCOM's Second Annual Global Life Science Partnering Conference is an exclusive global partnering and networking forum that brings together senior executives and business development professionals from leading pharmaceutical and biotech companies.
The conference will include case study presentations, individual company presentations, one-on-one meetings, and numerous networking opportunities.
Karen Bernstein, Chairman & Editor-in-Chief, BioCentury
Martin Birkhofer, Vice President of Strategic Transactions Group, Bristol-Myers Squibb
Miranda Biven, Partner, Wilson Sonsini Goodrich & Rosati
Ben Bonifant, Practice Area Leader, Campbell Alliance
Dan Burgess, CEO & Founder, Rempex Pharmaceuticals
Jerry Cobbs, Chief Commercialization Officer, Cancer Prevention & Research Institute of Texas
Keith Donnermeyer, Partner, Deloitte & Touche LLP
Mark Edwards, Managing Director, Bioscience Advisors
Luke Evnin, Managing Director, MPM Capital
Jennifer Friel Goldstein, Director, Pfizer Venture Investments
George Golumbeski, Senior Vice President Business Development, Celgene Corporation
Kurt Graves, Executive Chairman, Intarcia Therapeutics, Inc.
Faheem Hasnain, President & CEO, Receptos
Natasha Hernday, VP of Corporate Development, Seattle Genetics
Paul Laikind, Chief Business Officer and Senior VP of Business Development, Sanford Burnham Research Institute
Patrick Mahaffy, CEO & Founder, Clovis Oncology
Brian McVeigh, Vice President, WWBD Transactions and Investment Management, GlaxoSmithKline Pharmaceuticals
Teri Melese, Director, Director, Business Strategy & Development, School of Medicine, UCSF
Bob More, General Partner, Frazier Healthcare
Polly Murphy, Vice President, Worldwide Business Development, Pfizer
Mark Noguchi, Global Head of Alliance Management, Roche
Melinda Richter, Prescience International
Tony Rosenberg, Head of Global BD & Licensing, Novartis
Jim Schaeffer, Executive Director Worldwide Licensing & External Research, Merck Research Laboratories
Laura Shawver, CEO, Cleave BioSciences
Andy Schwab, Founder and Managing Partner, 5AM Ventures
Philippe Tinmouth, Vice President, Business Development & Alliance Management, Vertex Pharmaceuticals, Inc
Kurt von Emster, Managing Director, venBio LLC
Greg J. Wiederrecht, Vice President and Head, External Scientific Affairs, Merck & Co.
Mark Wiggins, Board Member, Zogenix
Planner Ashleigh Berry